1. Home
  2. VCEL vs MTRN Comparison

VCEL vs MTRN Comparison

Compare VCEL & MTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • MTRN
  • Stock Information
  • Founded
  • VCEL 1989
  • MTRN 1931
  • Country
  • VCEL United States
  • MTRN United States
  • Employees
  • VCEL N/A
  • MTRN N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • MTRN Industrial Specialties
  • Sector
  • VCEL Health Care
  • MTRN Industrials
  • Exchange
  • VCEL Nasdaq
  • MTRN Nasdaq
  • Market Cap
  • VCEL 2.1B
  • MTRN 2.3B
  • IPO Year
  • VCEL 1997
  • MTRN N/A
  • Fundamental
  • Price
  • VCEL $31.42
  • MTRN $114.58
  • Analyst Decision
  • VCEL Strong Buy
  • MTRN Strong Buy
  • Analyst Count
  • VCEL 6
  • MTRN 2
  • Target Price
  • VCEL $61.50
  • MTRN $123.50
  • AVG Volume (30 Days)
  • VCEL 677.8K
  • MTRN 111.3K
  • Earning Date
  • VCEL 11-06-2025
  • MTRN 10-29-2025
  • Dividend Yield
  • VCEL N/A
  • MTRN 0.50%
  • EPS Growth
  • VCEL 2045.40
  • MTRN N/A
  • EPS
  • VCEL 0.13
  • MTRN 0.78
  • Revenue
  • VCEL $249,119,000.00
  • MTRN $1,725,574,000.00
  • Revenue This Year
  • VCEL $18.35
  • MTRN $5.95
  • Revenue Next Year
  • VCEL $22.47
  • MTRN $6.78
  • P/E Ratio
  • VCEL $234.59
  • MTRN $143.56
  • Revenue Growth
  • VCEL 16.13
  • MTRN 5.52
  • 52 Week Low
  • VCEL $30.26
  • MTRN $69.10
  • 52 Week High
  • VCEL $63.00
  • MTRN $123.21
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 36.46
  • MTRN 61.32
  • Support Level
  • VCEL $30.26
  • MTRN $108.28
  • Resistance Level
  • VCEL $33.92
  • MTRN $114.08
  • Average True Range (ATR)
  • VCEL 1.52
  • MTRN 2.82
  • MACD
  • VCEL -0.22
  • MTRN -0.42
  • Stochastic Oscillator
  • VCEL 17.55
  • MTRN 97.17

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About MTRN Materion Corporation

Materion Corp specializes in the development of specialty engineered alloy systems, inorganic chemicals and powders, precious and non-precious metals, beryllium and beryllium composites, and precision filters and optical coatings. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Others. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms. The Performance Materials segment provides engineered solutions comprised of beryllium and non-beryllium-containing alloy systems and custom-engineered parts.

Share on Social Networks: